Switching to Biosimilars for RA, Part Two: My Experience as an ‘Outlier’ Trying (So Far) 3 Biosimilars
In April 2023, I received a letter from the Ontario government with information about the new biosimilar switching policy. I had until the end of the year to switch from the biologic medication I take to treat my rheumatoid arthritis (RA) to a biosimilar. I did my best to be hopeful and believe it would…
You May Have to Switch to a Biosimilar for Rheumatoid Arthritis. Here’s Why.
In March 2023, I received a letter from the Ontario government. It informed me that a biosimilar switching policy was now in place. People like me who receive funding from the government to pay for Biologics for rheumatoid arthritis (RA), Crohn’s disease, and other forms of autoimmune disease were given until the end of 2023…
Chronic News Bites: November
In a new monthly feature for HealthCentral, I provide snackable summaries of all the information that impacts your chronic life. This is November’s edition: “Grab yourself a hot beverage and get ready to click through some news you can really use. HealthCentral rheumatoid arthritis (RA) columnist Lene Andersen offers her monthly roundup of must-read news…
The Seated View Top 5 Posts in 2022
2022 was an interesting year. Here on The Seated View I had a bit of an involuntary blog hibernation as the challenges of life with chronic illness became pretty overwhelming. But in a fit of a well-rested post-holiday optimism, I decided it was time to reawaken this site of mine and what better way to…